FIBP
Acidic fibroblast growth factor intracellular-binding protein
Also known as: FGFIBP, FIBP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43427
- Gene
- FIBP
- Ensembl
- ENSG00000172500
- Chromosome
- 11
- Canonical length
- 364 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
Acidic fibroblast growth factor is mitogenic for a variety of different cell types and acts by stimulating mitogenesis or inducing morphological changes and differentiation. The FIBP protein is an intracellular protein that binds selectively to acidic fibroblast growth factor (aFGF). It is postulated that FIBP may be involved in the mitogenic action of aFGF. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
364 residues, UniProt reviewed canonical sequence.
>O43427|FIBP
1 MTSELDIFVG NTTLIDEDVY RLWLDGYSVT DAVALRVRSG ILEQTGATAA VLQSDTMDHY
61 RTFHMLERLL HAPPKLLHQL IFQIPPSRQA LLIERYYAFD EAFVREVLGK KLSKGTKKDL
121 DDISTKTGIT LKSCRRQFDN FKRVFKVVEE MRGSLVDNIQ QHFLLSDRLA RDYAAIVFFA
181 NNRFETGKKK LQYLSFGDFA FCAELMIQNW TLGAVGEAPT DPDSQMDDMD MDLDKEFLQD
241 LKELKVLVAD KDLLDLHKSL VCTALRGKLG VFSEMEANFK NLSRGLVNVA AKLTHNKDVR
301 DLFVDLVEKF VEPCRSDHWP LSDVRFFLNQ YSASVHSLDG FRHQALWDRY MGTLRGCLLR
361 LYHDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FIBP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 64 nTPM
- testis: 55 nTPM
- amygdala: 53 nTPM
- tongue: 53 nTPM
- heart muscle: 49 nTPM
- choroid plexus: 47 nTPM
Single-cell type
- late spermatids: 1,044 nCPM
- late primary spermatocytes: 226 nCPM
- decidual stromal cells: 184 nCPM
- early spermatids: 173 nCPM
- enterocytes: 172 nCPM
- extravillous trophoblasts: 167 nCPM
Immune cell
- myeloid DC: 165 nTPM
- non-classical monocyte: 151 nTPM
- intermediate monocyte: 137 nTPM
- basophil: 124 nTPM
- classical monocyte: 121 nTPM
- total PBMC: 109 nTPM
Brain region
- pons: 56 nTPM
- medulla oblongata: 54 nTPM
- cerebral cortex: 51 nTPM
- hypothalamus: 49 nTPM
- thalamus: 47 nTPM
- midbrain: 43 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FIBP.
Disease | AllUniProt
Conditions FIBP is implicated in, by any mechanism.
- Thauvin-Robinet-Faivre syndrome (TROFAS) MIM:617107
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 103 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Tall stature-intellectual disability-renal anomalies syndrome
- 6 conditions
- FIBP-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.04
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.03
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Acidic fibroblast growth factor intracellular-binding protein
- Acidic fibroblast growth factor binding (FIBP)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FIBP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FIBP as an antibody target. Whether an autoantibody or antibody against FIBP could matter depends on whether native FIBP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FIBP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FIBP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...